--- Chain 3 for Question 102 ---
Status: USED_FOR_VOTING
Finish Reason (Model): stop
Extracted Answer: D
Prompt Tokens (Usage): 439
Completion Tokens (Usage): 4367
Reasoning Tokens (Counted): 3869
Non-Reasoning Tokens (Counted): 496
Total Tokens (Usage): N/A

--- Reasoning Content ---
Okay, so I've got this pretty complex question about molecular biology, specifically about gene constructs and expression. Let me try to break it down step by step.

The question is about a ligand-receptor pair expressed in neural crest cells. The experiment involves creating a bicistronic vector, which means it has two genes in one construct. The setup is a bit tricky, so I need to visualize it.

The ligand has an ORF (open reading frame) at the 5' position, fused to mCherry. The receptor is at the 3' end, fused to eGFP at its C-terminus. The ligand is under the CBA promoter, which I think is a strong promoter. The receptor has an IRES regulatory element upstream, which allows for internal ribosome entry, so maybe the receptor is expressed as a separate protein.

There are stop cassettes with loxP and lox2272 in between the ligand and mCherry, and between the receptor and eGFP. So, the vector is set up so that without Cre, the stop signals prevent expression of mCherry and eGFP. But when Cre is introduced, it would recombine the lox sites, removing the stop cassettes, allowing the fluorescent proteins to be expressed.

Wait, no. I think I might have that backward. The ligand is at 5', so the vector is probably set up so that the first ORF is the ligand, followed by a stop with loxP, then the IRES, then the receptor ORF, then a stop with lox2272, and then eGFP. Or maybe it's the other way around.

Wait, the vector is bicistronic. So, each gene is under its own promoter? No, the ligand is under the CBA promoter. The receptor is under the IRES, which is a way to have two genes in one transcript, but I'm not sure. Wait, no, I think the CBA promoter is for the ligand, and the IRES is for the receptor. So, the vector likely has the CBA promoter driving the ligand, followed by a stop with loxP. Then comes the IRES, which would allow the receptor to be expressed. So each gene is in a separate cassette, but under the same transcript? Or maybe using internal ribosome entry for the receptor.

Wait, actually, bicistronic vectors often have two separate promoters or use IRES elements to allow for the translation of two proteins from a single transcript. So in this case, the ligand is under CBA promoter, then after that, a stop cassette with loxP. Then comes the IRES, which is a ribosome binding site for the receptor. So the transcript starts with the ligand, stops, and then the IRES allows the receptor to be translated. But with the stop cassettes in place, perhaps the fluorescent proteins aren't expressed until Cre is used to excise them.

Wait, the ligand ORF is followed by a stop in a loxP cassette, meaning that without Cre, the ligand is expressed, but the stop prevents mCherry from being expressed. Similarly, the receptor ORF is followed by a stop in a lox2272 cassette, preventing eGFP from being expressed. But when Cre is introduced, the lox sites are recognized, and the stop cassettes are removed, allowing the mCherry and eGFP to be expressed.

But wait, the question says that the ligand is under the CBA promoter, and the receptor is under the IRES. So, perhaps the vector is set up so that the CBA promoter drives the expression of the ligand, and the IRES allows for the expression of the receptor as a second gene. But the stops in the lox cassettes prevent the fluorescent tags from being expressed unless Cre is present.

So the idea is that without Cre, you just get the ligand and receptor expressed, but the fluorescent tags are not, because the stops are in place. When you have Cre, it should delete the stop cassettes, so mCherry and eGFP are expressed, allowing you to track the expression of the ligand and receptor.

The experiment is done in primary astrocyte culture. The person made a mouse model that's homozygous for this construct in the wild-type background. Then they crossed it with SOX10-Cre hemizygous mice. SOX10 is a transcription factor important in neural crest development, so the Cre would be expressed where SOX10 is active, which is in the neural crest derivatives, like astrocytes.

After the offspring are born, they're visualized under a confocal microscope looking for green signal, which comes from eGFP. But they didn't see a green signal. So why?

The options are:

A) ligand and receptor are in a paracrine relationship. Paracrine means they act on nearby cells. But I'm not sure how that would prevent eGFP expression. Unless they're secreted and not expressed on the cell surface, but the question says they're initially expressed in neural crest cells, which are transmembrane and coiled-coil (so maybe secreted?).

B) Receptor-eGFP construct is stuck in the Golgi. So it's not trafficked to the cell surface, so the eGFP wouldn't be visible. That's possible. But why would Cre affect that? Because the construct would have the receptor with eGFP. If the construct is correctly made, the eGFP should be expressed when Cre is present.

C) The enhancer for ligand and receptor expression is missing. So the promoters aren't working. But the ligand is under CBA, which is a strong promoter; the receptor is under IRES, so maybe it's expressed at lower levels. But if the construct isn't expressed, you wouldn't see any signal. But the person used the antibodies and ran a Western blot, which showed signals proportional to actin. So maybe the proteins are being expressed.

Wait, the Western blot was after plasmid transfection. So when they transfected the plasmid into primary astrocytes, they used the antibodies against the overexpressed proteins and saw the signals. That suggests that the ligand and receptor are expressed when the plasmid is present, but in the mouse model, which is using the SOX10-Cre to activate the construct, they didn't see the GFP.

So the construct is in the mouse, and when Cre is present (from SOX10-Cre), the stops are removed, allowing eGFP and mCherry to be expressed. But in the mouse, when they look for GFP, they don't see it.

But why?

Looking at the options, D says the receptor and eGFP are not in frame. Oh, wait. If the stop cassette is between the receptor ORF and eGFP, then the stop would prevent the eGFP from being expressed unless Cre deletes it. But if the stop is deleted but the eGFP isn't in frame, that could cause issues.

Wait, but the stops are in loxP and lox2272 cassettes. So when Cre is introduced, the lox sites are recognized and the stop is removed. So, the eGFP should be expressed as part of the construct.

Wait, but the vector has the receptor ORF followed by a stop in a lox2272 cassette, then eGFP. So the construct is:

ligand (CBA-driven) --> stop (loxP) --> IRES --> receptor --> stop (lox2272) --> eGFP.

Wait, no, the way it's described: the ligand is at 5' (with its own promoter), followed by a stop in a loxP cassette. Then, the receptor is at 3' with IRES upstream and a stop in a lox2272 cassette before eGFP.

Wait, perhaps the vector is:

Promoter (CBA) -> ligand ORF -> loxP-stop-loxP -> IRES -> receptor ORF -> lox2272-stop-lox2272 -> eGFP.

So in the absence of Cre, the ligand is expressed, but the stop after ligand prevents mCherry from being expressed. The IRES would allow the receptor ORF to be expressed, but the stop after receptor stops eGFP. So when Cre is introduced, the loxP sites (in the ligand's stop cassette) should be recombined, removing the stop, so mCherry is expressed downstream of ligand. Similarly, the lox2272 sites would be recombined, removing the stop, allowing eGFP to be expressed.

Wait, but the ligand is fused to mCherry, and the receptor is fused to eGFP. So when Cre is present, the stops are removed, allowing the fluorescent proteins to be expressed.

But in the mouse model, they crossed with SOX10-Cre, which should mean that in the neural crest-derived cells, Cre is active. So in those cells, the stops are removed, and eGFP should be expressed. So why no green signal?

Looking at the options, D says the receptor and eGFP are not in the same frame. If the stop is removed, but the cloning wasn't done correctly, perhaps the eGFP is not in frame after the receptor. Suppose the vector has the receptor ORF followed by a stop, and then eGFP. But when the stop is deleted via Cre, the reading frame might shift, making a frameshift that causes the eGFP to not be expressed properly, or not at all.

Alternatively, if the cloning didn't preserve the frame, the eGFP might not be expressed correctly. So in the mouse model, the eGFP is not being expressed, hence no green signal.

Wait, another possibility is if the IRES is not functional. Since the receptor is under IRES, but IRES allows internal initiation. If the IRES isn't working, then the receptor might not be expressed. But in the Western blot, after transfection, they saw signals. So the construct works when transfected into cells, but in the mouse, maybe the IRES isn't active in the same way.

But why would that be? Maybe the IRES requires certain conditions, like a particular cell type or environment. But the question says they crossed with SOX10-Cre, which is probably driving expression in the same cells where the IRES is supposed to function.

Alternatively, perhaps the eGFP is not being correctly expressed because the frame is wrong.

Wait, the vector is set up so that the ligand is fused to mCherry, meaning that the ligand's stop is between the ligand and mCherry. The receptor is followed by a stop, then eGFP. If the stop is removed via Cre, the receptor ORF is followed by eGFP. So the transcription would result in a longer mRNA, but with the receptor and eGFP in the same reading frame?

No, because the stop is between the receptor and eGFP. So the stop is in a lox2272 cassette, so when Cre deletes it, the receptor is directly followed by eGFP. So the eGFP would be in frame with the receptor? Or is it a separate ORF?

Wait, the way the vector is designed: the receptor ORF is followed by a stop cassette. So the mRNA for the receptor ends with the stop. When Cre removes the stop, the eGFP is now in frame with the receptor? That doesn't make sense because the eGFP would be a separate ORF. Unless the stop is removed and the eGFP is added as a separate ORF.

Wait, I think the vector is designed such that the eGFP is downstream of the receptor with a stop in between. So when Cre deletes the stop, the eGFP is expressed as a separate ORF, but only when the stop is removed.

But if the stop is in a lox2272 cassette, perhaps the lox sites are on either side of the stop, so when Cre is present, the stop is excised and the eGFP is expressed as a separate gene, in frame with the receptor? Or perhaps not.

Wait, perhaps the vector is such that the receptor is followed by a stop, and then the eGFP is after that. So when the stop is removed, the mRNA would have the receptor followed by eGFP, but as two separate ORFs. So the eGFP would be expressed as a separate protein.

But if the stop is not correctly excised, or if the cloning leads to the eGFP not being in frame, then when the stop is removed, the eGFP wouldn't be expressed correctly.

Alternatively, another possibility is that the stop is present, so eGFP isn't expressed, but when Cre deletes it, the reading frame is altered, leading to a frameshift and no eGFP expression.

Wait, the initial setup says that the ligand ORF is at 5' and fused to mCherry, with a stop in a loxP cassette. So the ligand is expressed, but without Cre, the mCherry isn't. Similarly, the receptor is at 3' with a stop in a lox2272 cassette, followed by eGFP.

So, when Cre is present (from SOX10-Cre), the loxP sites in the ligand's stop cassette are recombined, removing the stop, allowing mCherry to be expressed as a fusion with the ligand. Similarly, the lox2272 sites are recombined, removing the stop between receptor and eGFP, allowing eGFP to be expressed.

But if the eGFP is not in frame, perhaps the stop wasn't correctly removed, or the vector was cloned such that the eGFP is in a different frame, leading to no expression.

Alternatively, if the eGFP is not being translated, perhaps it's a matter of the vector not being correctly spliced.

Alternatively, perhaps the problem is that the IRES isn't working, so the receptor isn't being expressed. But earlier, they saw expression in the Western blot, so in the transfected cells, the construct works.

Wait, but in the mouse model, the Cre is SOX10-driven, which is active in neural crest cells. So the ligand and receptor should be expressed, and the fluorescent proteins should be expressed as well.

But the problem is that they didn't see the eGFP. So why?

Another thought: the lox sites are different. The ligand's stop is in a loxP cassette, and the receptor's stop is in a lox2272 cassette. So when Cre is introduced, both stops are removed. But if the mouse model is homozygous for the construct, and Cre is only present in some cells, but the construct is being recombined in others.

Wait, but in the question, they didn't see any green signal, suggesting that eGFP wasn't expressed at all.

Alternatively, perhaps the antibodies aren't working, but that's not one of the options.

Looking back at the options, option D says the receptor and eGFP are not in frame. If the vector is such that the stop is between the receptor and eGFP, but when Cre deletes the stop, perhaps the eGFP is in the wrong reading frame relative to the receptor. So the eGFP won't be expressed because it's part of a different ORF.

Wait, but the ligand and mCherry are in frame, because they're fused. So the ligand is followed by mCherry without a stop. The stop is in a lox cassette between the ligand and mCherry. So when Cre deletes the stop, the ligand and mCherry are co-expressed.

Similarly, the receptor is followed by a stop. When the stop is deleted, the eGFP is expressed. So perhaps the construct has the receptor ORF, then a stop, then eGFP. So when Cre deletes the stop, the mRNA now contains the receptor followed by eGFP, but as a single ORF? No, that doesn't make sense. They're separate genes, so they should be separate ORFs.

Wait, perhaps the vector is designed so that the eGFP is in the same ORF as the receptor after the stop is removed. That would be a problem because the two proteins would be part of a single large protein, which is not intended. So unless they are in frame, but that's only possible if the stop is removed and the eGFP is added in frame, which would require precise cloning.

But the question says that the ligand is fused to mCherry, which are presumably in frame. So the ligand ORF is followed by mCherry, but a stop is in a loxP cassette. So when Cre deletes the stop, the ligand and mCherry are co-expressed.

Similarly, the receptor is followed by a stop, and then eGFP. If the stop is in a lox2272 cassette, when Cre deletes it, the receptor and eGFP are co-expressed as a single ORF? That can't be right, because that would create a fusion protein, which isn't intended.

Wait, perhaps the eGFP is in the same ORF as the receptor. So the stop is between them, and when the stop is removed, the eGFP is in the same reading frame as the receptor, making a larger protein. But that's not intended, so the eGFP wouldn't be expressed as a fluorescent protein but as part of a larger, nonfunctional protein.

Alternatively, the stop is followed by eGFP in a separate ORF. So after the stop is removed, the mRNA is read as two separate ORFs: receptor and eGFP. But for that to happen, the stop must be removed, and the eGFP must be in frame.

If the stop wasn't correctly removed, or the eGFP isn't in frame, then the eGFP won't be expressed.

So the most likely reason for no green signal is that the eGFP isn't expressed because it's not in frame with the receptor. Hence, option D is correct.


--- Final Answer Content ---


The question involves a bicistronic vector expressing a ligand and receptor, with fluorescent tags (mCherry and eGFP) under stop cassettes flanked by loxP and lox2272 sites. The ligand is under the CBA promoter, and the receptor is under an IRES element. In the absence of Cre, the stop cassettes prevent expression of the fluorescent tags. Upon Cre-mediated excision of the stop cassettes, mCherry and eGFP should be expressed. However, in the mouse model, no green signal (eGFP) was observed under the confocal microscope.

### Key Analysis of Options:
1. **Option A (Ligand and receptor are in a paracrine relationship):**  
   While paracrine signaling involves secreted ligands acting on nearby cells, this does not explain the absence of eGFP expression in the construct. The question focuses on the expression of the receptor-eGFP fusion, not its functional relationship.

2. **Option B (Receptor-eGFP construct is stuck in the Golgi):**  
   If the receptor-eGFP construct were stuck in the Golgi, it would not reach the cell surface, and eGFP would not be visible. However, the absence of eGFP expression is more likely due to a failure in transcription or translation, rather than trafficking issues.

3. **Option C (Enhancer for ligand and receptor expression is missing):**  
   The ligand is under the strong CBA promoter, and the receptor is under an IRES element, which should allow expression in the absence of additional enhancers. The absence of eGFP is not due to a missing enhancer.

4. **Option D (Receptor and eGFP are not in frame):**  
   The vector is designed such that the receptor ORF is followed by a stop cassette, which is excised by Cre to allow eGFP expression. If the stop cassette is not properly excised or if the eGFP is not in the correct reading frame relative to the receptor, eGFP would not be expressed. This is the most likely explanation for the absence of the green signal.

### Conclusion:
The absence of the green signal is best explained by the receptor and eGFP not being in the correct reading frame, preventing proper expression of eGFP. 

**Answer: D**